|
| ID |
DDInter462 |
| Drug Type |
small molecule |
| Molecular Formula |
C23H20F3N5O2S2 |
| Molecular Weight |
519.572
|
| Description |
Dabrafenib is a kinase inhibitor used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer.
|
| ATC Classification |
L01XE23
|
| IUPAC Name |
N-{3-[5-(2-Aminopyrimidin-4-Yl)-2-Tert-Butyl-1,3-Thiazol-4-Yl]-2-Fluorophenyl}-2,6-Difluorobenzene-1-Sulfonamide |
| InChI |
Inchi=1S/C23H20F3N5O2S2/C1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25/H4-11,31H,1-3H3,(H2,27,28,29) |
| InChI Key |
BFSMGDJOXZAERB-UHFFFAOYSA-N |
| Canonical SMILES |
CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|